With 2.3 billion doses delivered globally, AstraZeneca’s Covid-19 shot—shunned by the West—proves popular elsewhere and is neck and neck with China’s Sinovac in vaccines distributed
LONDON— AstraZeneca PLC’s Covid-19 vaccine isn’t authorized in the U.S., and governments in Canada, Australia and across Western Europe have shunned it after production problems and rare but sometimes-deadly side effects.
In much of the rest of the world, though, it is a crucial workhorse vaccine, reaching more people in lower- and lower-middle-income countries than any other Western-made shot. It also has run neck and neck with a shot by China’s Sinovac Biotech Ltd. and one developed by Pfizer Inc. and Germany’s BioNTech SE for overall doses distributed globally.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CityMD temporarily closes 19 locations amid surge in COVID-19 casesUrgent care chain CityMD announced it is temporarily closing more than a dozen of its 150 locations in New York and New Jersey amid a surge in COVID-19 cases and increased demands for testing.
Read more »
Novavax Says Early Data Shows Covid-19 Vaccine Protects Against OmicronNovavax said early data indicates its Covid-19 vaccine demonstrated “strong immune responses” against the Omicron variant and other variants of the coronavirus
Read more »
Should people be paid to get the COVID-19 vaccine or booster?A financial incentive can help convince more people to get the vaccine or booster, supporters say. But critics worry a payment can send the wrong message.
Read more »
2021 Notebook: The COVID-19 pandemic and the vaccine rollout | AP NewsTHE BACKGROUND: The year started with a lot of promise. The world had vaccines. And even as the planet reached 2 million dead by the middle of the month of January, people in many of the hard-hit countries, including the United States and Britain, began rolling up their sleeves and receiving the life-saving shots.
Read more »
U.S. Army Developing Its Own COVID-19 VaccineThe U.S. Army is conducting clinical trials on a vaccine designed to be effective against COVID-19 and its variants, the website Defense One reported. It's a 'soccer ball-shaped protein with 24 faces.' Learn more:
Read more »